| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 88.86B | 92.93B | 86.50B | 81.10B | 64.66B | 52.24B |
| Gross Profit | 23.39B | 22.87B | 22.39B | 22.16B | 17.42B | 14.32B |
| EBITDA | 7.70B | 7.90B | 8.13B | 8.90B | 8.32B | 6.16B |
| Net Income | 2.48B | 5.95B | 4.07B | 6.23B | 4.40B | 3.63B |
Balance Sheet | ||||||
| Total Assets | 108.94B | 120.22B | 115.62B | 101.56B | 90.08B | 80.02B |
| Cash, Cash Equivalents and Short-Term Investments | 17.60B | 18.33B | 17.11B | 13.40B | 11.88B | 13.53B |
| Total Debt | 18.54B | 22.20B | 24.36B | 16.12B | 16.51B | 16.61B |
| Total Liabilities | 53.49B | 59.60B | 59.20B | 48.92B | 44.55B | 38.74B |
| Stockholders Equity | 55.06B | 60.20B | 56.03B | 52.31B | 45.18B | 40.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.24B | -4.83B | -501.00M | 407.00M | -363.00M |
| Operating Cash Flow | 0.00 | 4.53B | -668.00M | 2.86B | 1.25B | 3.13B |
| Investing Cash Flow | 0.00 | -260.00M | -1.56B | 424.00M | -1.28B | -4.85B |
| Financing Cash Flow | 0.00 | -4.00B | 5.85B | -3.31B | -2.19B | -2.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥49.97B | 13.44 | ― | 3.47% | 8.25% | -7.58% | |
77 Outperform | ¥73.38B | 15.48 | ― | 2.79% | 4.22% | 7.91% | |
72 Outperform | ¥182.91B | 15.90 | 10.28% | 2.77% | 4.61% | 1.98% | |
68 Neutral | ¥38.57B | 10.70 | ― | 3.32% | 17.04% | -5.21% | |
65 Neutral | ¥197.80B | 13.93 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥70.94B | 12.05 | ― | 3.09% | 7.43% | 47.68% |